<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ijohns
   </journal-id>
   <journal-title-group>
    <journal-title>
     International Journal of Otolaryngology and Head &amp; Neck Surgery
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2168-5452
   </issn>
   <issn publication-format="print">
    2168-5460
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ijohns.2025.146039
   </article-id>
   <article-id pub-id-type="publisher-id">
    ijohns-147302
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Surgical Management of Primary Hyperparathyroidism: A Study of 9 Cases
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Birame
      </surname>
      <given-names>
       Loum
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Faddy
      </surname>
      <given-names>
       Attye
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Fallou
      </surname>
      <given-names>
       Niang
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Thierno Boubacar
      </surname>
      <given-names>
       Diallo
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Cheikhna Ba
      </surname>
      <given-names>
       Ndiaye
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abibou
      </surname>
      <given-names>
       Ndiaye
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Khady Marie Agnes
      </surname>
      <given-names>
       Diouf
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aUniversite Cheikh Anta Diop, Dakar, Senegal
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     26
    </day> 
    <month>
     09
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    14
   </volume> 
   <issue>
    06
   </issue>
   <fpage>
    363
   </fpage>
   <lpage>
    373
   </lpage>
   <history>
    <date date-type="received">
     <day>
      12,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      16,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      16,
     </day>
     <month>
      November
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Introduction</b>
    <b>:</b> Primary hyperparathyroidism (pHPT) is defined by an excessive secretion of parathyroid hormone (PTH) that remains elevated relative to serum calcium levels. Its incidence is steadily increasing, with a marked predominance in women. The definitive diagnosis is biological, while imaging is essential to localize the parathyroid lesion and guide surgical treatment. 
    <b>Objective:</b> To analyze the epidemiological, clinical, therapeutic, and prognostic features of patients who underwent surgery for primary hyperparathyroidism. 
    <b>Materials and Methods:</b> Retrospective analysis involving 9 patients who underwent surgery for primary hyperthyroidism between January 2014 and December 2017. Results: The most represented age group in our series was [60 - 80 years], the average age was 66.3 years, with an extreme at 48 and 77 years. A female predominance was observed (78%), osseous manifestations of hypercalcemia were the dominant presentation, Serum calcium levels were elevated in 100% of patients, and iPTH levels were elevated in all cases. A topographic diagnosis was made based on imaging findings, cervical ultrasound was performed on 6 patients, while cervico-thoracic CT was conducted in 56% of the cases. All patients received preoperative treatment to reduce serum calcium levels involved rehydration and diuretics. The surgical approach consisted of a classic transverse cervicotomy. Post-operative recovery was uneventful. Pathological examination revealed a parathyroid adenoma in 100% of the patients. 
    <b>Conclusion:</b> Primary hyperparathyroidism (pPTH) is the most common endocrine disorder in adults after thyroid diseases. It is incidentally discovered in more than 50% of the cases. Surgical intervention remains the definitive treatment of symptomatic forms, despite emerging medical alternatives. Transverse cervicotomy has proven effective and remains a reliable and accessible treatment option in our context, until minimally invasive surgery become more widely available.
   </abstract>
   <kwd-group> 
    <kwd>
     Surgery
    </kwd> 
    <kwd>
      Parathyroid
    </kwd> 
    <kwd>
      Hypercalcemia
    </kwd> 
    <kwd>
      Adenoma
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Primary hyperparathyroidism (pHPT) is defined by an inappropriate increase in the secretion of parathyroid hormone (PTH) relative to calcium levels, resulting from both an increased number and activity of parathyroid cells.</p>
   <p>Its incidence is approximately 28 cases per 100,000 individuals <xref ref-type="bibr" rid="scirp.147302-1">
     [1]
    </xref>. pHPT is generally discovered when asymptomatic, often presenting with only mild hypercalcemia, making it a frequent incidental finding.</p>
   <p>Surgery remains essential, particularly in younger patients and in symptomatic or progressive forms of the disease <xref ref-type="bibr" rid="scirp.147302-2">
     [2]
    </xref> <xref ref-type="bibr" rid="scirp.147302-3">
     [3]
    </xref>.</p>
   <p>In this retrospective study of 9 cases of surgically managed primary hyperparathyroidism, we aimed to examine the epidemiological and clinical profiles of the condition within our local context and to discuss the therapeutic strategies, with a particular focus on surgical management.</p>
  </sec><sec id="s2">
   <title>2. Materials and Methods</title>
   <p>We retrospectively studied patients diagnosed with primary hyperparathyroidism, and managed surgically between January 1<sup>st</sup> 2014 and December 31<sup>st</sup> 2017 in our head and neck department. All patients with complete records were included and unusable records were excluded. The data source included patients’ medical records and operative reports.</p>
  </sec><sec id="s3">
   <title>3. Results</title>
   <sec id="s3_1">
    <title>3.1. Epidemiological Study</title>
    <p>The age of the patients at the time of diagnosis ranged from 48 to 77 years, with a mean age of 66.3 years, only one patient (11%) was from the age group of 40 to 60 years, while the remaining eight (89%) were from 60 to 80 years.</p>
    <p>There was a female predominance in our cohort: 7 women (78%) and 2 men (22%), with sex ratio (M/F) of 0.3.</p>
   </sec>
   <sec id="s3_2">
    <title>3.2. Medical History</title>
    <p>All female patients were post-menopausal. Three of our patients were previously diagnosed with primary hyperthyroidism, five patients (55%) had a history of hypertension. One patient presented with a history of hyperthyroidism. Two patients had undergone abdominal surgery one for nephrolithiasis and the other for cholelithiasis. A history of miscarriage was reported in three female patients (33%), one patient (11%) reported alcohol consumption, no history of smoking was reported among the patients.</p>
   </sec>
   <sec id="s3_3">
    <title>3.3. Presentation and Symptoms (<xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>)</title>
    <p>Seven patients (78%) presented with generalized inflammatory bone pain, often associated with diffuse myalgia. One patient (11%) reports arthralgia. Five patients (56%) describe muscle cramps in the lower limbs. Four patients (44%) experienced palpitations. Constipation was reported by three patients (33%) during the months preceding their consultation. One patient (11%) presented with epigastric pain. In one case, hypercalcemia was incidentally discovered during routine laboratory tests performed as part of anemia workup.</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Figure 1. Distribution of patients according to clinical manifestations.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2461081-rId15.jpeg?20251119100017" />
    </fig>
   </sec>
   <sec id="s3_4">
    <title>3.4. Physical Examination</title>
    <p>Six patients (67%) presented with deterioration of general condition, the symptoms included fatigue, unquantified weight loss, unspecified anorexia. One patient (11%) exhibited mental disturbances. A gait abnormality was observed in one patient (11%).</p>
   </sec>
   <sec id="s3_5">
    <title>3.5. Paraclinical Investigation</title>
    <p>Serum parathyroid hormone (PTH) concentration was measured in seven patients. In four cases, the value was twice the upper limit of the normal range. In the remaining three cases, PTH levels were mildly elevated: 69.96 and 94 pg/mL respectively. Serum calcium concentration ranged from 106 to 165 mg/mL, with a mean value of 135.5 mg/mL. Hyperphosphatemia was detected in one patient (11%). Elevated 24-hour urinary calcium (&gt;6.25 mmol/24 h). Excretion was observed in two cases. Serum alkaline phosphatase was elevated in two patients (&gt;125 UI/l). All patients had a normal renal function.</p>
    <p>Six patients underwent cervical USG, revealing a single parathyroid nodule in all cases (100%), and associated thyroid nodules in two cases (33%).</p>
    <p>Five patients underwent a cervical CT scan, which also revealed a single parathyroid nodule in each case. Associated thyroid nodules were observed in 2 cases.</p>
   </sec>
   <sec id="s3_6">
    <title>3.6. Surgical Treatment</title>
    <p>All patients received appropriate preoperative preparation, including rehydration, diuretic therapy, and monitoring of both cardiac and renal functions. Each patient in our series underwent parathyroidectomy through a standard transverse cervicotomy (<xref ref-type="fig" rid="fig2">
      Figure 2
     </xref>) with excision of a single parathyroid nodule.</p>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Figure 2. Surgical approach to the parathyroid gland, under the thyroid lobe.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2461081-rId16.jpeg?20251119100019" />
    </fig>
    <p>Although the location varied, the lesions were predominantly located in the inferior parathyroid glands (89%) (<xref ref-type="fig" rid="fig3">
      Figure 3
     </xref>), illustrates the distribution of patients based on the surgical procedure performed.</p>
    <fig id="fig3" position="float">
     <label>Figure 3</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Figure 3. Distribution of patients according to the surgical procedure performed.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2461081-rId17.jpeg?20251119100019" />
    </fig>
    <p>A lobo-isthmectomy and a total thyroidectomy were performed in two cases (22%).</p>
   </sec>
   <sec id="s3_7">
    <title>3.7. Outcome</title>
    <p>The post-operative course was uneventful for all patients (<xref ref-type="fig" rid="fig4">
      Figure 4
     </xref> and <xref ref-type="fig" rid="fig5">
      Figure 5
     </xref>), with normalization of serum calcium levels. Vomiting was observed in one case, which resolved after the administration of antiemetics.</p>
    <fig id="fig4" position="float">
     <label>Figure 4</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Figure 4. Patient in the immediate post-operative period.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2461081-rId18.jpeg?20251119100020" />
    </fig>
    <fig id="fig5" position="float">
     <label>Figure 5</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Figure 5. Patient in the distant post-operative period.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2461081-rId19.jpeg?20251119100020" />
    </fig>
    <p>Two months postoperatively the patients returned with normal serum calcium and phosphorus levels</p>
    <p>During the 5 years follow-up, no recurrence was observed. clinical examination was normal, total calcium (2.2 to 2.6 mmol/l) and PTH levels (15 to 65 pg/ml) were normal.</p>
   </sec>
   <sec id="s3_8">
    <title>3.8. Pathological Examination</title>
    <p>In our series, histopathology revealed a single parathyroid adenoma in all cases (100%) (<xref ref-type="fig" rid="fig6">
      Figure 6
     </xref>).</p>
    <fig id="fig6" position="float">
     <label>Figure 6</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Figure 6. Surgical specimen of a parathyroid adenoma.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/2461081-rId20.jpeg?20251119100020" />
    </fig>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <sec id="s4_1">
    <title>4.1. Epidemiology</title>
    <p>Claire BLANCHARD-LOUIS in Nantes reported a mean age of 68 years <xref ref-type="bibr" rid="scirp.147302-4">
      [4]
     </xref>. HARIGA et al. in Tunisia observed a mean age of 56.5 years <xref ref-type="bibr" rid="scirp.147302-5">
      [5]
     </xref>. Both studies noted that the age at the diagnosis was over 50 years, which was also the case in our series.</p>
    <p>
     <xref ref-type="bibr" rid="scirp.147302-"></xref>Our cohort showed a female predominance with 78% female and 22% male patients. <xref ref-type="table" rid="table1">
      Table 1
     </xref> presents the predominant sex reported by various authors.</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Table 1. Predominant sex reported in international series.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Series</p></td> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Country</p></td> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Predominant Sex</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter"><p style="text-align:center">Claire-BLANCHARD (2012) <xref ref-type="bibr" rid="scirp.147302-4">
          [4]
         </xref> (n = 116)</p></td> 
       <td class="custom-top-td acenter"><p style="text-align:center">France (Nantes)</p></td> 
       <td class="custom-top-td acenter"><p style="text-align:center">Female (78%)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">S. Miller (2008) <xref ref-type="bibr" rid="scirp.147302-6">
          [6]
         </xref> (n = 1066)</p></td> 
       <td class="acenter"><p style="text-align:center">United states</p></td> 
       <td class="acenter"><p style="text-align:center">Female (74%)</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Our series (n = 9)</p></td> 
       <td class="acenter"><p style="text-align:center">Senegal (Dakar)</p></td> 
       <td class="acenter"><p style="text-align:center">Female (78%)</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>n: Number of cases.</p>
   </sec>
   <sec id="s4_2">
    <title>4.2. Diagnosis</title>
    <p>Primary hyperparathyroidism can be discovered through various clinical presentations:</p>
    <p>In our series, all patients initially sought consultation in general medicine. The most common symptoms of hypercalcemia including fatigue, weight loss and osseous manifestations were observed in 78% of cases.</p>
    <p>One patient was asymptomatic, with hypercalcemia discovered incidentally.</p>
    <p>Our findings differ from those of M. KHEDER <xref ref-type="bibr" rid="scirp.147302-7">
      [7]
     </xref> who found that the majority of the cases were discovered through hypercalcemia in laboratory tests, most of which were asymptomatic.</p>
    <p>In the present study, osseous manifestations were the most common (78%), including bone pain, arthralgia, and abnormal gait. General symptoms were the second most frequent (67%), such as fatigue and weight loss. One case of depressive disorder (11%) was noted. <xref ref-type="table" rid="table2">
      Table 2
     </xref> summarizes the clinical signs reported in various international studies.</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Table 2. Frequency of clinical signs in international series.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="cell-with-diagonal-border aright" colspan="2"><p style="text-align:right">Series</p><p style="text-align:left">Signes</p></td> 
       <td class="acenter"><p style="text-align:center">Claire Blanchard</p><p style="text-align:center">2012 <xref ref-type="bibr" rid="scirp.147302-4">
          [4]
         </xref></p><p style="text-align:center">(n = 116)</p></td> 
       <td class="acenter"><p style="text-align:center">Hariga</p><p style="text-align:center">2007 <xref ref-type="bibr" rid="scirp.147302-5">
          [5]
         </xref></p><p style="text-align:center">(n = 25)</p></td> 
       <td class="acenter"><p style="text-align:center">Our Series</p><p style="text-align:center">2018</p><p style="text-align:center">(n = 9)</p></td> 
      </tr> 
      <tr> 
       <td rowspan="2" class="acenter"><p style="text-align:center">General</p></td> 
       <td class="acenter"><p style="text-align:center">Fatigue</p></td> 
       <td class="acenter"><p style="text-align:center">76%</p></td> 
       <td rowspan="2" class="acenter"><p style="text-align:center">28%</p></td> 
       <td rowspan="2" class="acenter"><p style="text-align:center">67%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Weight loss</p></td> 
       <td class="acenter"><p style="text-align:center">53%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" colspan="2"><p style="text-align:center">Osseous</p></td> 
       <td class="acenter"><p style="text-align:center">44%</p></td> 
       <td class="acenter"><p style="text-align:center">40%</p></td> 
       <td class="acenter"><p style="text-align:center">78%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" colspan="2"><p style="text-align:center">Renal</p></td> 
       <td class="acenter"><p style="text-align:center">---</p></td> 
       <td class="acenter"><p style="text-align:center">44%</p></td> 
       <td class="acenter"><p style="text-align:center">---</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" colspan="2"><p style="text-align:center">Cardiovascular</p></td> 
       <td class="acenter"><p style="text-align:center">45%</p></td> 
       <td class="acenter"><p style="text-align:center">28%</p></td> 
       <td class="acenter"><p style="text-align:center">44%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" colspan="2"><p style="text-align:center">Digestive</p></td> 
       <td class="acenter"><p style="text-align:center">---</p></td> 
       <td class="acenter"><p style="text-align:center">36%</p></td> 
       <td class="acenter"><p style="text-align:center">44%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" colspan="2"><p style="text-align:center">Neuropsychiatric</p></td> 
       <td class="acenter"><p style="text-align:center">50%</p></td> 
       <td class="acenter"><p style="text-align:center">---</p></td> 
       <td class="acenter"><p style="text-align:center">11%</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>n: Number of cases.</p>
   </sec>
   <sec id="s4_3">
    <title>
     <xref ref-type="bibr" rid="scirp.147302-"></xref>4.3. Laboratory Findings</title>
    <p>In our series, serum calcium levels were above the normal range in 100%, as were iPTH levels. Two patients had elevated 24-hour urinary calcium excretion.</p>
    <p>In 2007 HARIGA et al. <xref ref-type="bibr" rid="scirp.147302-5">
      [5]
     </xref> reported that 92% of their patients had elevated serum calcium levels with a mean range of 115mg/L. 24-hour urinary calcium excretion was above the normal range in 72% of the patients and normal in 28%. iPTH were elevated in 100% with a mean value of 405 pg/mL</p>
   </sec>
   <sec id="s4_4">
    <title>4.4. Imaging</title>
    <p>In the 2007 series of M Tassart et al. <xref ref-type="bibr" rid="scirp.147302-8">
      [8]
     </xref> in Paris, the sensitivity of the USG was 85%.</p>
    <p>Our results are higher with a sensitivity of 100% of USG. However, the size of our simple requires some cautions.</p>
    <p>In our series, a CT scan was conducted in five patients and confirmed the diagnosis in all cases, resulting in sensitivity of 100%. As reported by the authors the sensitivity and specificity of the CT scan are 70% and 90% respectively, slightly more accurate compared to ultrasound <xref ref-type="bibr" rid="scirp.147302-9">
      [9]
     </xref>.</p>
   </sec>
   <sec id="s4_5">
    <title>4.5. Treatment</title>
    <p>There are two main approaches:</p>
    <p>In our series, all patients who presented with hypercalcemia (100%) received hypocalcemic treatment consisting of furosemide and rehydration. Moreover, no patient received bone-targeted or etiological treatment.</p>
    <p>A parathyroidectomy with excision of a single nodule was performed in 100% of the cases. The nodule exhibited variable locations, with a predominance in the inferior parathyroid region.</p>
    <p>HARIGA <xref ref-type="bibr" rid="scirp.147302-5">
      [5]
     </xref> also realized excision of a single nodule in 88% of the cases.</p>
   </sec>
   <sec id="s4_6">
    <title>4.6. Histopathology</title>
    <p>In our series, parathyroid adenoma accounted for 100% of the cases.</p>
    <p>
     <xref ref-type="table" rid="table3">
      Table 3
     </xref> compares our results of histological findings with those of international series.</p>
    <p>
     <xref ref-type="bibr" rid="scirp.147302-"></xref></p>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Table 3. Frequency of histological types according to the literature.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">International series</p></td> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Year (Country)</p></td> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Adenoma</p></td> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Hyperplasia</p></td> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Carcinoma</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter"><p style="text-align:center">Inabnet (n = 100) <xref ref-type="bibr" rid="scirp.147302-11">
          [11]
         </xref></p></td> 
       <td class="custom-top-td acenter"><p style="text-align:center">2002 (United States)</p></td> 
       <td class="custom-top-td acenter"><p style="text-align:center">96%</p></td> 
       <td class="custom-top-td acenter"><p style="text-align:center">1%</p></td> 
       <td class="custom-top-td acenter"><p style="text-align:center">3%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Dhioub (n = 34) <xref ref-type="bibr" rid="scirp.147302-12">
          [12]
         </xref></p></td> 
       <td class="acenter"><p style="text-align:center">2006 (Tunisia)</p></td> 
       <td class="acenter"><p style="text-align:center">76%</p></td> 
       <td class="acenter"><p style="text-align:center">23%</p></td> 
       <td class="acenter"><p style="text-align:center">0%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Barbier <xref ref-type="bibr" rid="scirp.147302-13">
          [13]
         </xref></p></td> 
       <td class="acenter"><p style="text-align:center">1992</p></td> 
       <td class="acenter"><p style="text-align:center">97.2%</p></td> 
       <td class="acenter"><p style="text-align:center">1%</p></td> 
       <td class="acenter"><p style="text-align:center">1.8%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Ryan <xref ref-type="bibr" rid="scirp.147302-14">
          [14]
         </xref></p></td> 
       <td class="acenter"><p style="text-align:center">1997</p></td> 
       <td class="acenter"><p style="text-align:center">98%</p></td> 
       <td class="acenter"><p style="text-align:center">2%</p></td> 
       <td class="acenter"><p style="text-align:center">0%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Our series (n = 9)</p></td> 
       <td class="acenter"><p style="text-align:center">2018 (Senegal)</p></td> 
       <td class="acenter"><p style="text-align:center">100%</p></td> 
       <td class="acenter"><p style="text-align:center">0%</p></td> 
       <td class="acenter"><p style="text-align:center">0%</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>In all international series, as well as in ours, parathyroid adenoma is by far the most commonly found pathological lesion in pHPT.</p>
   </sec>
   <sec id="s4_7">
    <title>4.7. Postoperative Outcome</title>
    <p>
     <xref ref-type="bibr" rid="scirp.147302-"></xref>The post-operative course was uneventful in the majority of the cases 98% <xref ref-type="bibr" rid="scirp.147302-">
      [
     </xref><xref ref-type="bibr" rid="scirp.147302-15">
      15]
     </xref>.</p>
    <p>However, a strict monitoring protocol should be implemented:</p>
    <p>-Clinical monitoring: assessing for hypocalcemia signs such as muscle cramps, tingling in the extremities, paresthesia, and numbness.</p>
    <p>-Biological monitoring: immediate postoperative monitoring of serum calcium levels on Day 0, Day 1 and Day 8 <xref ref-type="bibr" rid="scirp.147302-16">
      [16]
     </xref>.</p>
    <p>Acute hypocalcemia and recurrent laryngeal nerve paralysis <xref ref-type="bibr" rid="scirp.147302-12">
      [12]
     </xref> <xref ref-type="bibr" rid="scirp.147302-13">
      [13]
     </xref> are the main immediate postoperative complications. Serum calcium levels typically drop the most between the first and the third postoperative days.</p>
    <p>In Barbier et al. <xref ref-type="bibr" rid="scirp.147302-13">
      [13]
     </xref> multicenter study, the rate of permanent recurrent laryngeal nerve paralysis in 1.5% in 4883 patients who underwent traditional cervicoctomy.</p>
    <p>In our study, no cases of hypocalcemia, recurrent laryngeal nerve paralysis, or hematoma were reported. similarly, no late complications such as postoperative hypoparathyroidism, renal insufficiency or acute pancreatitis were observed.</p>
    <p>
     <xref ref-type="bibr" rid="scirp.147302-"></xref>Proye, in a series of 1888 patients, a 97.6% success rate was attained after primary standard cervicotomy <xref ref-type="bibr" rid="scirp.147302-17">
      [17
     </xref><xref ref-type="bibr" rid="scirp.147302-17">
      ]
     </xref>. This rate is close to those typically reported in other series, which range around 95% <xref ref-type="bibr" rid="scirp.147302-18">
      [18]
     </xref>.</p>
    <p>In our study, we achieved a 100% success rate with classic cervicotomy, with full recovery.</p>
    <p>The risk of failure can be minimized by exploring the ipsilateral gland and searching for an ipsilateral supernumerary gland. The causes are multiples. <xref ref-type="table" rid="table4">
      Table 4
     </xref> presents the main causes of primary hyperparathyroidism recurrence.</p>
    <table-wrap id="table4">
     <label>
      <xref ref-type="table" rid="table4">
       Table 4
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.147302-"></xref>Table 4. Main causes of recurrence according to Proye <xref ref-type="bibr" rid="scirp.147302-17">
        [17]
       </xref>.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">Ectopic gland</p></td> 
       <td class="custom-bottom-td acenter"><p style="text-align:center">35%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter"><p style="text-align:center">Incomplete exploration</p></td> 
       <td class="custom-top-td acenter"><p style="text-align:center">32%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Supernumerary gland</p></td> 
       <td class="acenter"><p style="text-align:center">23%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Assessment error</p></td> 
       <td class="acenter"><p style="text-align:center">22%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Incomplete gland resection</p></td> 
       <td class="acenter"><p style="text-align:center">16%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Second localization</p></td> 
       <td class="acenter"><p style="text-align:center">13%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Development of secondary HPT</p></td> 
       <td class="acenter"><p style="text-align:center">3%</p></td> 
      </tr> 
      <tr> 
       <td class="acenter"><p style="text-align:center">Diagnostic error</p></td> 
       <td class="acenter"><p style="text-align:center">3%</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>In our series, there was no recurrence observed during the 5 years follow up period.</p>
    <p>
     <xref ref-type="bibr" rid="scirp.147302-"></xref>The findings from our study align with data from international cohorts, which demonstrate a very low recurrence rate following surgical treatment <xref ref-type="bibr" rid="scirp.147302-5">
      [5]
     </xref> <xref ref-type="bibr" rid="scirp.147302-17">
      [17]
     </xref>. According to our results, transverse cervicotomy has demonstrated its effectiveness and remains an efficient and accessible therapeutic approach our countries, until minimally invasive surgery <xref ref-type="bibr" rid="scirp.147302-19">
      [19]
     </xref> <xref ref-type="bibr" rid="scirp.147302-20">
      [20]
     </xref> become more widely available.</p>
   </sec>
  </sec><sec id="s5">
   <title>5. Conclusions</title>
   <p>Primary hyperparathyroidism (pHPT) is the second most common endocrine disorder in adults following thyroid diseases, affecting women more often, it is incidentally discovered in 50% of the cases.</p>
   <p>The curative treatment for symptomatic cases remains surgical, despite emerging medical alternatives.</p>
   <p>Transverse cervicotomy remains an efficient and accessible therapeutic approach for less advanced countries.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.147302-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Conrad, D.N., Olson, J.E., Hartwig, H.M., Mack, E. and Chen, H. (2006) A Prospective Evaluation of Novel Methods to Intraoperatively Distinguish Parathyroid Tissue Utilizing a Parathyroid Hormone Assay. Journal of Surgical Research, 133, 38-41. &gt;https://doi.org/10.1016/j.jss.2006.02.029 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bilezikian, J.P., Potts Jr, J.T., Fuleihan, G.E., Kleerekoper, M., Neer, R., Peacock, M., et al. (2002) Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century. The Journal of Clinical Endocrinology&amp;Metabolism, 87, 5353-5361. &gt;https://doi.org/10.1210/jc.2002-021370 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Calzada-Nocaudiem, M., Chanson, P., Conte Delvox, B., et al. (2004) Prise en charge de l’hyperparathyroïdie primaire asymptomatique. Consensus d’expert de la SFE. Annales d’Endocrinologie, 67, 7-12.
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Blanchard, C., Mathonnet, M., Sebag, F., Caillard, C., Hamy, A., Volteau, C., et al. (2013) Surgery for ‘Asymptomatic’ Mild Primary Hyperparathyroidism Improves Some Clinical Symptoms Postoperatively. European Journal of Endocrinology, 169, 665-672. &gt;https://doi.org/10.1530/eje-13-0502 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hariga, I., Zribi, S., Khamassi, K., Gamra, O., Skouri, Y., Amor, M., et al. (2007) Prise en charge de l’hyperparathyroidie primaire: A propos de 25 cas et revue de la littérature. Journal Tunisien d’ORL et de Chirurgie Cervico-Faciale, 19, 6-9. &gt;https://doi.org/10.4314/jtdorl.v19i1.57878 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Miller, B.S., Dimick, J., Wainess, R. and Burney, R.E. (2008) Age-and Sex-Related Incidence of Surgically Treated Primary Hyperparathyroidism. World Journal of Surgery, 32, 795-799. &gt;https://doi.org/10.1007/s00268-007-9427-2 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Khedher, M., Rachdi, I., Aydi, Z., Baili, L., Bendhaw, B. and Boussem, F. (2016) Hyperparathyroïdie primaire: À propos de 29 observations. Annales d’Endocrinologie, 77, 449-450. &gt;https://doi.org/10.1016/j.ando.2016.07.580 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tassart, M., Bah, O., Perie, S., Lefevre, M., Facon, D., Gibeault, M., et al. (2007) Hyperparathyroidie primaire: Apport de l’echographie et de la scinti MIBI au reperage preoperatoire des glandes parathyroides. Journal de Radiologie, 88, 1447. &gt;https://doi.org/10.1016/s0221-0363(07)81371-0 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tibblin, S. and Bizard, J.P. (1991) Primary Hyperparathyroidism Due to Solitary Adenoma. A Comparative Study of Different Surgical Regiments. European Journal of Surgery, 157, 511-521.
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shoback, D.M., Bilezikian, J.P., Turner, S.A., McCary, L.C., Guo, M.D. and Peacock, M. (2003) The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism. The Journal of Clinical Endocrinology&amp;Metabolism, 88, 5644-5649. &gt;https://doi.org/10.1210/jc.2002-021597 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Inabnet, W.B. and Biertho, L. (2002) Chirurgie parathyroïdienne dirigée : une série de 100 patients consécutifs. Annales de Chirurgie, 127, 751-756. &gt;https://doi.org/10.1016/s0003-3944(02)00875-1 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dhouib, H., Hammami, B., Ben Thabet, A. and Drira, M.M. (2006) Traitement Chirurgical de L’hyperparathyroidie Primaire: Techniques et Resultats. Journal Tunisien d’ORL et de Chirurgie Cervico-Faciale, 16, 8-11. &gt;https://doi.org/10.4314/jtdorl.v16i1.42053 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Barbier, J., Denizot, A. and Henry, J.F. (1992) Aspect chirurgical actuel de l’hyperparath-yroïdisme primaire. Chirurgie, 118, 439-447.
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ryan, J.A. and Lee, F. (1997) Effectiveness and Safety of 100 Consecutive Parathyroidectomies. The American Journal of Surgery, 173, 441-444. &gt;https://doi.org/10.1016/s0002-9610(97)00074-3 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Clark, O.H. (2003) How Should Patients with Primary Hyperparathyroidism Be Treated? The Journal of Clinical Endocrinology&amp;Metabolism, 88, 3011-3014. &gt;https://doi.org/10.1210/jc.2003-030588 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dehesdin, D., Guerrier, B., Santini, J., Zanaret, M. and Le Clech, G. (2008) Adénome parathyroïdien. Annales d’Otolaryngologie et de Chirurgie Cervico-Faciale, 125, 78-84. &gt;https://doi.org/10.1016/j.aorl.2007.04.009 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Arnalsteen, L., Quievreux, J.L., Huglo, D., Pattou, F., Carnaille, B. and Proye, C. (2004) Réinterventions pour hyperparathyroïdisme primaire persistant ou récidivant. Soixante-dix-sept cas sur 1888 opérés. Annales de Chirurgie, 129, 224-231. &gt;https://doi.org/10.1016/j.anchir.2004.03.007 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Silverberg, S.J., Shane, E., Jacobs, T.P., Siris, E. and Bilezikian, J.P. (1999) A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery. New England Journal of Medicine, 341, 1249-1255. &gt;https://doi.org/10.1056/nejm199910213411701 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cacciatore, G., Mastronardi, M., Paiano, L., Abdallah, H., Crisafulli, C., Dore, F., et al. (2025) How Has the Diagnostic Approach to Parathyroid Localization Techniques Evolved in the Past Decade? Insights from a Single-Center Experience. Updates in Surgery, 77, 389-399. &gt;https://doi.org/10.1007/s13304-025-02090-8 
    </mixed-citation>
   </ref>
   <ref id="scirp.147302-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chi, S.Y., Kuo, C.Y. and Cheng, S.P. (2024) Temporal Research Trends in Parathyroid Surgery. The American Journal of Surgery, 237, Article 115941. &gt;https://doi.org/10.1016/j.amjsurg.2024.115941
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>